D. Jayaprakash1, N. Swathi
D. Jayaprakash1, N. Swathi1*
1Former Principal, Department of Pharmacy, University College of Technology, Osmania University, Hyderabad, 500007, Telangana, India.
2Research Scholar, Department of Pharmacy, University College of Technology, Osmania University, Hyderabad, 500007, Telangana, India.
Volume - 14,
Issue - 2,
Year - 2021
Rosuvastatin is a statin medication used to prevent cardiovascular disease in those patients who are at high risk and also to treat abnormal lipids. Rosuvastatin is a HMG-Co-A inhibitor used for the treatment of hyperlipidemia and atherosclerosis disease. The main objective of the study was to prepare Rosuvastatin Mouth Dissolving Films. The absolute oral bioavailability of rosuvastatin is found to be 20% due to its extensive first pass effect after oral dosing. Rosuvastatin Mouth Dissolving Films are prepared with a combination of hydrophilic polymers like HPMC, Lycoat and HEC with superdisintegrants CCS and SSG. PEG 400 was used as a plasticizer. Citric acid was used as a saliva stimulating agent. All the films are prepared with different drug polymer ratios to study the effect of weight fraction of carrier on dissolution rate of the drug. The films readily dissolved in the dissolution medium. In-vitro parameters like thickness, disintegration, folding endurance, assay, weight of the films, % elongation of the films were evaluated for all the 15 formulations. The drug release profiles of the drug from the films were investigated. Preformulation studies like compatability studies with polymers using FTIR, DSC, XRD and SEM studies were carried out. The drug and the polymers were found to be compatible with each other. The release of the Rosuvastatin from the films was found to be 98.74% in 20min in the dissolution medium (pH 6.8 phosphate buffers). The drug release profiles of the films were analyzed using UV-visible spectrophotometer at 246nm. The prepared 15 formulations of rosuvastatin were also evaluated for percentage drug release at various time intervals. The results are shown that ROS 2 formulation was best in terms of drug content and drug release.
Cite this article:
D. Jayaprakash1, N. Swathi. Formulation and Characterization of Rosuvastatin Mouth dissolving films for the treatment of Hyperlipidemia. Research J. Pharm. and Tech. 2021; 14(2):997-1002. doi: 10.5958/0974-360X.2021.00178.5
D. Jayaprakash1, N. Swathi. Formulation and Characterization of Rosuvastatin Mouth dissolving films for the treatment of Hyperlipidemia. Research J. Pharm. and Tech. 2021; 14(2):997-1002. doi: 10.5958/0974-360X.2021.00178.5 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-2-74
1. Y. Rojanasakul, L.-Y. Wang, M. Bhat, D. D. Glover, C. J. Malanga, and J. K. H. Ma, Pharm. Res. (1992). 9, 1029.
2. A. V. Gore, A. C. Liang, and Y. W. Chein, Journal of Pharmaceutical Sciences. 1998, 87, 441.
3. A. H. Shojaei, Journal of Pharmaceutical. Sciences. 1998. 1:15.
4. M. Malke, S. Shidhaye, and V. J. Kadam, Indian Journal of Pharmaceutical. Sciences. 2007; 69: 211.
5. Deore VA. Development and statistical optimization of mucoadhesive buccal patches of indomethacin: in-vitro and ex-vivo evaluation. International journal of advances in pharmacy biology and chemistry. 2013; 2: 405-422.
6. Nafee NA, Fatma A, Nabila A, Lobna M. Mucoadhesive buccal patches of miconazole nitrate in vitro/in vivo performance and effect of aging. International Journal of Pharmacy, 2003; 264: 1-14.
7. Chang RK, Guo X, Burnside BA, Couch RA. Fast dissolving tablets. Pharmaceutical Technology 2000; 24(6): 52-58.
8. Reddy LH, Ghosh BR. Fast dissolving drug delivery systems: A review of literature. Indian Journal of Pharmaceutical Sciences. 2002; 64 (4): 331-336.
9. Kuchekar BS, Arumugam V. Fast dissolving tablets. Indian Journal of Pharmaceutical Education 2001; 5: 150.
10. Kakadiya Jagdish. Causes, symptoms, pathophysiology and diagnosis of atherosclerosis. Pharmacology online, 2009; 3: 420-442.
11. R Patel, N Shardul, J Patel, A Baria. Archives of Pharmaceutical Sciences and Research. 2009; 1(2): 212-217.
12. Uppal N, Goswami DS, Kashyap S, Sharma K, Mona S, Dhaliwal H. Development and evaluation of transdermal drug delivery system of captopril. International Journal of University Pharmacy and Bio Sciences. 2013; 2(3): 298-305.
13. M. Nishimura, K. Matsuura, H. Yamashita, N. Inagaki, T. Sugiyama, Y. Itoh, International Journal of Pharmacy. 2009; 368; 98.
14. H. Shimoda, K. Taniguchi, M. Nishimura, K. Matsuura, T. Tsukioka, H. Yamashita, European. Journal of Pharmaceutics and. Biopharmaceutics. 2009; 73: 361.